Mein Warenkorb

IL-1RL1

IL-1RL1 Molekülinformation

Englischer NameInterleukin-1 receptor-like 1Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5Target-AliasST2,IL1RL1,Protein ST2,DER4,T1,Interleukin 1 Receptor Like 1,Homolog Of Mouse Growth Stimulation-Expressed,Interleukin 1 Receptor-Related Protein,Growth Stimulation-Expressed,FIT-1,IL33R,ST2L,ST2V,Interleukin-1 Receptor-Like 1 Protein,EC:3.2.2.6,Interleukin-1 Receptor-Like 1
Höchste Forschungs- und EntwicklungsphaseNDA/BLA
Englischer NameInterleukin-1 receptor-like 1
Target-AliasST2,IL1RL1,Protein ST2,DER4,T1,Interleukin 1 Receptor Like 1,Homolog Of Mouse Growth Stimulation-Expressed,Interleukin 1 Receptor-Related Protein,Growth Stimulation-Expressed,FIT-1,IL33R,ST2L,ST2V,Interleukin-1 Receptor-Like 1 Protein,EC:3.2.2.6,Interleukin-1 Receptor-Like 1
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5
Höchste Forschungs- und EntwicklungsphaseNDA/BLA

IL-1RL1 Produktliste

  • Attribut

    Protein (5)

  • Produktbibliothek

    Online (5)

  • Spezies

    Human (4)Mouse (1)

  • Etikett

    His Tag (1)Fc Tag (2)His Tag & Avi Tag (1)Fc Tag & Avi Tag (1)

  • Marker

    Unconjugated (3)Biotin-labeled (2)

IL-1RL1 Molekülhintergrund

Interleukin 1 receptor-like 1 (IL1RL1) is also known as ST2, DER4, FIT-1, IL33R, ST2L, ST2V, which belongs to the interleukin-1 receptor family. IL1RL1 contains three Ig-like C2-type (immunoglobulin-like) domains and one TIR domain. IL1RL1 is receptor for interleukin-33 (IL-33), its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8. IL1RL1 possibly involved in helper T-cell function. IL1RL1 can interact with MYD88, IRAK1, IRAK4, and TRAF6.

IL-1RL1 Molekülalias

IL1RL1,DER4,FIT-1,IL33R,ST2,ST2L,ST2V,T1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
AstegolimabAMG-282; RG-6149; RO-7187807Phase 3 ClinicalAmgen Inc, F. Hoffmann-La Roche LtdCoronavirus Disease 2019 (COVID-19); Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
Details
AK-139AK139; AK-139Phase 2 ClinicalKangfang Biotechnology (Cayman) Co LtdAsthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Hypersensitivity; Prurigo Nodularis; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal
Details
TQC-2938TQC2938; TQC-2938Phase 2 ClinicalNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical GroupAsthma; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Seasonal
Details
Recombinant humanized anti-ST2 monoclonal antibody9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdAsthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
Details
NEROFEPhase 1 ClinicalImmune System Key LtdNeoplasms; Solid tumours
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns